Exploring the Risks, Protocols and Principles of Success in This Type of Deal
Contributed by ContentLive, featuring Mark Herndon, President M&A Partners
The risks involved in so-called ‘mergers of equals’ must be carefully managed if a deal’s objectives are to be achieved and its many potential pitfalls avoided.
In one of the biggest business deals of 2014, US chemical giants DuPont and Dow Chemical announced in December that they would merge, a deal currently valued at $130bn.
Following a unanimous vote in favour of the action, the boards of directors from both companies hailed the move as a ‘merger of equals’, announcing that the combined company would be known as DowDuPont. But, given the reality – that strategies have to converge, boards have to marry and assets have to combine – can a merger ever really be equal?
Read the entire article HERE.